Document is current
Any future updates will be listed below
-
Authors
Oka, Itsuki
Toyokawa, Yoshiaki
Imai, Kouta
Nakagawa, Tatsuya
Tourtas, Theofilos
Schlötzer-Schrehardt, Ursula
Kruse, Friedrich
Koizumi, Noriko
Okumura, Naoki
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (KAKENHI Grant (18K09464))
- License Information
-
More Information
Article History
Received: 5 January 2025
Accepted: 18 March 2025
First Online: 26 April 2025
Declarations
:
: Naoki Okumura and Noriko Koizumi are co-founders of ActualEyes Inc., which is currently developing a pharmaceutical therapy for treating Fuchs endothelial corneal dystrophy. Other authors do not have a competing financial interest.
